Anthropic and other leading AI companies are pushing health care and biology to the center of their public case for AI as criticism over job losses, energy use and data-center construction intensifies. The strategy combines products that help people navigate care today with longer-term promises of faster drug discovery and disease research.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.